Kumar, R., Singh, S.K., Singh, S. and Kumar , A. 2025. Addressing cardio-metabolic risks in type 2 diabetes: evidence-based insights on efpeglenatide. International Journal of Basic & Clinical Pharmacology. 14, 4 (Jun. 2025), 565–582. DOI:https://doi.org/10.18203/2319-2003.ijbcp20251843.